63 related articles for article (PubMed ID: 459603)
1. [Role of secondary hyperaldosteronism in the pathomecanism of hydropic decompensation in the cirrhotic patient (author's transl)].
García Puig J; Gancedo González P; Mateos Antón F; Herrero Huerta E; Muro González J; Ortíz Vázquez J
Med Clin (Barc); 1979 May; 72(9):369-74. PubMed ID: 459603
[TBL] [Abstract][Full Text] [Related]
2. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
[TBL] [Abstract][Full Text] [Related]
3. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
Colantonio D; Casale R; Pasqualetti P
Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
[TBL] [Abstract][Full Text] [Related]
5. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Burghardt W; Müller R; Diehl KL; Wernze H
Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
[TBL] [Abstract][Full Text] [Related]
6. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
7. [Renal, hemodynamic and hormonal effects of repeated water immersion in liver cirrhosis].
Christoph C; Held C; Scholze HJ
Gastroenterol J; 1990; 50(4):183-6. PubMed ID: 2151113
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
9. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
10. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
11. [What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?].
Albert JP; Hartmann F
Med Klin; 1981 Jan; 76(3):74-7. PubMed ID: 7219332
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
[TBL] [Abstract][Full Text] [Related]
13. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T
Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis.
Tulassay T; Tulassay Z; Rascher W
Gastroenterol J; 1990; 50(3):140-3. PubMed ID: 2149634
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
La Villa G; Laffi G; Pinzani M; Pampana A; Mannelli M; Smorlesi C; Gentilini P
Boll Soc Ital Biol Sper; 1984 Mar; 60(3):535-41. PubMed ID: 6561965
[TBL] [Abstract][Full Text] [Related]
16. [Neurohumoral activity in liver cirrhosis].
Lazúrová I; Rosochová I; Lichardus B; Trejbal D; Hildebrand T; Tkác I; Machánová Y; Murár J
Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
Burghardt W; Wernze H; Diehl KL
Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055
[TBL] [Abstract][Full Text] [Related]
20. [The renin-angiotensin-aldosterone system during the extraction, concentration and reinfusion of ascitic fluid in cirrhotic patients].
Giorcelli V; Fossale PG
Arch Sci Med (Torino); 1983; 140(3):273-80. PubMed ID: 6675585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]